Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nimotuzumab in newly diagnosed glioblastoma multiforme
NCT00753246Phase 3Completed
- Sponsor
- Oncoscience AG
- Start
- Aug 2007
- Countries
- 1
01
Overview
A Phase 3 trial of nimotuzumab in glioblastoma multiforme (GBM), sponsored by Oncoscience AG. Started Aug 2007; status: completed.
02
Drugs
nimotuzumab
03
Conditions
glioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT00753246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00753246.